semaglutide and eye disease Ozempic Blindness Lawsuit [2026 Update] Semaglutide and other GLP-1 drugs

The FDA-approved prescribing information for Wegovy specifically includes a warning about heart rate increase and recommends monitoring heart rate at regular intervals, particularly when initiating treatment and increasing the dose

Additionally, DSIP may promote endorphin release, contributing to its potential pain-relief benefits

A secondary benefit of semaglutide therapy is weight loss , with clinical trials showing average reductions of approximately 3-6 kg (or 3-6% of body weight) over 30-56 weeks in people with type 2 diabetes

This is especially useful for people with B vitamin deficiencies who may feel tired or fatigued throughout the day

Inject OZEMPIC subcutaneously in the abdomen, thigh, or upper arm